Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 106

Sort by

Sort Order Select

Journal Articles

The Incidence, Clinical Application and Prognostic Significance of MYD88 and CXCR4 Mutation in Chinese Patients with Lymphoplasmacytic Lymphoma/ Waldenström Macroglobulinemia

Ying Yu, Yuting Yan, Jun Wang, Wenjie Xiong, Yao Yao, Yanshan Huang, Rui Lyu, Tingyu Wang, Qi Wang, Wei Liu, Gang An, Weiwei Sui, Yan Xu, Wenyang Huang, Dehui Zou, Zhijian Xiao, Lugui Qiu, Shuhua Yi

Blood (2023) 142 (Supplement 1): 6089.

https://doi.org/10.1182/blood-2023-188786

Published: 2023

Journal Articles

Allele-Specific Expression of Leukemia Genes Is Associated with Pathogenicity in Poor Risk AML

Blood (2023) 142 (Supplement 1): 1389.

https://doi.org/10.1182/blood-2023-184516

Published: 2023

Journal Articles

The XPO1-FOXC1-HOX Functional Axis Opens New Therapeutic Avenues to Treat DEK-NUP214 AML Patients

Blood (2023) 142 (Supplement 1): 4302.

https://doi.org/10.1182/blood-2023-174891

Published: 2023

Journal Articles

Longitudinal Single Cell Analyses Reveal the Co-Evolutionary Dynamics of the Tumor and Microenvironment Accompanying Follicular Lymphoma Transformation

Megan Perrett, Lucy Pickard, Emil Kumar, Giuseppe Palladino, Faraz Khan, Carina Edmondson, Connor Knight, Edward Poynton, Janet Matthews, Shamzah Araf, Andrew James Clear, Maria Calaminici, John G. Gribben, Hamish King, Mirjana Efremova, Jun Wang, Jessica Okosun

Blood (2022) 140 (Supplement 1): 748–749.

https://doi.org/10.1182/blood-2022-159995

Published: 2022

Journal Articles

Data of Daratumumab from a Real-World Single-Center Study

Jun Wang, Jiafei Wu, Xi Yang, Hong Zheng, Yijing Wang, Boyue Zheng, Feiyang Li, Hui Li

Blood (2022) 140 (Supplement 1): 12650.

https://doi.org/10.1182/blood-2022-170588

Published: 2022

Journal Articles

Deep Multi-Omics Profiling in Cytogenetically Poor-Risk AML

Blood (2022) 140 (Supplement 1): 1030–1032.

https://doi.org/10.1182/blood-2022-159069

Published: 2022

Journal Articles

Outcome and Molecular Measurable Residual Disease Monitoring in Adult B-Cell Acute Lymphoblastic Leukemia Patients with MEF2D Fusions

Kai Sun, Wen-Min Chen, Xu Wang, Xiao-Su Zhao, Ling-Di Li, Yue Hao, Jun Wang, Nan Xu, Hao Jiang, Lan-Ping Xu, Yu Wang, Xiao-Hui Zhang, Qian Jiang, Xiao Jun Huang, Ya-Zhen Qin

Blood (2022) 140 (Supplement 1): 11864–11865.

https://doi.org/10.1182/blood-2022-159866

Published: 2022

Journal Articles

Differential Gene Expression in Circulating T-Cells in Long-Term Adolescent/Young Adult Hodgkin Lymphoma (AYAHL) Survivors and Their Unaffected Twins

Wendy Cozen, Marta Epeldegui, David V. Conti, Amie E. Hwang, Jun Wang, Larry Magpantay, Thomas M. Mack, Otoniel Martinez-Maza, Steve W Cole

Blood (2021) 138 (Supplement 1): 1332.

https://doi.org/10.1182/blood-2021-154131

Published: 2021

Journal Articles

The Landscape of Immunoglobulin Heavy Chain Gene Repertoire in Lymphoplasmacytic Lymphoma / Waldenström Macroglobulinemia

Blood (2021) 138 (Supplement 1): 1346.

https://doi.org/10.1182/blood-2021-149397

Published: 2021

Journal Articles

Vitamin B5 and Succinyl-CoA Improve Ineffective Erythropoiesis in SF3B1 Mutated Myelodysplasia

Syed Mian, Celine Philippe, Eleni Maniati, Tiffany Bergot, Marion Piganeau, Doriana Di Bella, Valle Morales, Andrew Finch, Katiuscia Bianchi, Jun Wang, Paolo Gallipoli, Uwe Platzbecker, Daniel H Wiseman, Dominique Bonnet, Delphine Bernard, John Gribben, Kevin Rouault-Pierre

Blood (2021) 138 (Supplement 1): 324.

https://doi.org/10.1182/blood-2021-147726

Published: 2021

Journal Articles

KDM5 inhibition offers a novel therapeutic strategy for the treatment of KMT2D mutant lymphomas

Blood (2021) 138 (5): 370–381.

https://doi.org/10.1182/blood.2020008743

Published: 2021

Includes: Supplemental data

Journal Articles

This Is a Title: Single-Center Data Report of Clhag Regimen for R/R-AML Patients

Chuanyan Jiang, Yu Wang, Mengying Zou, Yijing Wang, Jun Wang, Jiafei Wu, Xi Yang, Hui LI, MD

Blood (2020) 136 (Supplement 1): 3.

https://doi.org/10.1182/blood-2020-139708

Published: 2020

Journal Articles

This Is a Title: Cytarabine Combined with PD-1 Inhibitor in the Treatment of R/R-AML: A Report of 3 Cases and Literature Review

Yu Wang, Chuanyan Jiang, Xi Yang, Jingying Dai, PhD, Mengying Zou, Yijing Wang, Jun Wang, Jiafei Wu, Hui LI, MD

Blood (2020) 136 (Supplement 1): 26.

https://doi.org/10.1182/blood-2020-139729

Published: 2020

Journal Articles

Integration of Deep Multi-Omics Profiling Veals New Insights into the Biology of Poor-Risk Acute Myeloid Leukemia

Blood (2020) 136 (Supplement 1): 39–40.

https://doi.org/10.1182/blood-2020-141345

Published: 2020

Journal Articles

Systematic Evaluation of Somatic Cis -Regulatory Mutations in Follicular Lymphoma

Firat Uyulur, MSc, Findlay Bewicke-Copley, PhD MSc, BSc, Chinedu Anthony Anene, PhD, Matthias Schlesner, PhD, Icgc MMML-Seq Project, Reiner Siebert, Prof. Dr. MD, Jessica Okosun, MD PhD, Jude Fitzgibbon, PhD, Jun Wang, PhD

Blood (2020) 136 (Supplement 1): 26–27.

https://doi.org/10.1182/blood-2020-142623

Published: 2020

Journal Articles

E2A-PBX1 functions as a coactivator for RUNX1 in acute lymphoblastic leukemia

Wen-Chieh Pi, Jun Wang, Miho Shimada, Jia-Wei Lin, Huimin Geng, Yu-Ling Lee, Rui Lu, Dongxu Li, Gang Greg Wang, Robert G. Roeder, Wei-Yi Chen

Blood (2020) 136 (1): 11–23.

https://doi.org/10.1182/blood.2019003312

Published: 2020

Includes: Supplemental data

Journal Articles

Longitudinal Analyses of Diagnostic-Relapse Biopsies of Diffuse Large B Cell Lymphoma Reveal a Poor Risk Subset of ABC Patients Based on the Expression of a 30 Gene Panel

Blood (2019) 134 (Supplement_1): 2769.

https://doi.org/10.1182/blood-2019-124352

Published: 2019

Journal Articles

Immunotherapy targeting 4-1BB: mechanistic rationale, clinical results, and future strategies

Cariad Chester, Miguel F. Sanmamed, Jun Wang, Ignacio Melero

Blood (2018) 131 (1): 49–57.

https://doi.org/10.1182/blood-2017-06-741041

Published: 2018

Journal Articles

PD-1H (VISTA) Induces Immune Evasion in Acute Myeloid Leukemia

Tae Kon Kim, MD PhD, Xue Han, PhD, Jun Wang, PhD, Miguel Sanmamed, MD, Tianxiang Zhang, PhD, Stephanie Halene, MD PhD, Manoj M Pillai, MD, Jun Lu, PhD, Mina Xu, MD, Amer M. Zeidan, MD, Steven D. Gore, MD, Madhav V Dhodapkar, MBBS, Lieping Chen, MD PhD

Blood (2017) 130 (Supplement 1): 2658.

https://doi.org/10.1182/blood.V130.Suppl_1.2658.2658

Published: 2017

Journal Articles

Genomic Profiling Reveals Spatial Intra-Tumor Heterogeneity in Follicular Lymphoma

Blood (2017) 130 (Supplement 1): 2730.

https://doi.org/10.1182/blood.V130.Suppl_1.2730.2730

Published: 2017

NARROW

The Incidence, Clinical Application and Prognostic Significance of MYD88 and CXCR4 Mutation in Chinese Patients with Lymphoplasmacytic Lymphoma/ Waldenström Macroglobulinemia

Allele-Specific Expression of Leukemia Genes Is Associated with Pathogenicity in Poor Risk AML

The XPO1-FOXC1-HOX Functional Axis Opens New Therapeutic Avenues to Treat DEK-NUP214 AML Patients

Longitudinal Single Cell Analyses Reveal the Co-Evolutionary Dynamics of the Tumor and Microenvironment Accompanying Follicular Lymphoma Transformation

Data of Daratumumab from a Real-World Single-Center Study

Deep Multi-Omics Profiling in Cytogenetically Poor-Risk AML

Outcome and Molecular Measurable Residual Disease Monitoring in Adult B-Cell Acute Lymphoblastic Leukemia Patients with MEF2D Fusions

Differential Gene Expression in Circulating T-Cells in Long-Term Adolescent/Young Adult Hodgkin Lymphoma (AYAHL) Survivors and Their Unaffected Twins

The Landscape of Immunoglobulin Heavy Chain Gene Repertoire in Lymphoplasmacytic Lymphoma / Waldenström Macroglobulinemia

Vitamin B5 and Succinyl-CoA Improve Ineffective Erythropoiesis in SF3B1 Mutated Myelodysplasia

KDM5 inhibition offers a novel therapeutic strategy for the treatment of KMT2D mutant lymphomas

This Is a Title: Single-Center Data Report of Clhag Regimen for R/R-AML Patients

This Is a Title: Cytarabine Combined with PD-1 Inhibitor in the Treatment of R/R-AML: A Report of 3 Cases and Literature Review

Integration of Deep Multi-Omics Profiling Veals New Insights into the Biology of Poor-Risk Acute Myeloid Leukemia

Systematic Evaluation of Somatic Cis -Regulatory Mutations in Follicular Lymphoma

E2A-PBX1 functions as a coactivator for RUNX1 in acute lymphoblastic leukemia

Longitudinal Analyses of Diagnostic-Relapse Biopsies of Diffuse Large B Cell Lymphoma Reveal a Poor Risk Subset of ABC Patients Based on the Expression of a 30 Gene Panel

Immunotherapy targeting 4-1BB: mechanistic rationale, clinical results, and future strategies

PD-1H (VISTA) Induces Immune Evasion in Acute Myeloid Leukemia

Genomic Profiling Reveals Spatial Intra-Tumor Heterogeneity in Follicular Lymphoma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only